These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2411304)

  • 61. Cholecystokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholism.
    Geracioti TD; Nicholson WE; Orth DN; Ekhator NN; Loosen PT
    Brain Res; 1993 Dec; 629(2):260-8. PubMed ID: 8111629
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CSF calcium: clinical correlates in affective illness and schizophrenia.
    Jimerson DC; Post RM; Carman JS; van Kammen DP; Wood JH; Goodwin FK; Bunney WE
    Biol Psychiatry; 1979 Feb; 14(1):37-51. PubMed ID: 420907
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recurrent affective syndromes in bipolar and unipolar mood disorders at follow-up.
    Goldberg JF; Harrow M; Grossman LS
    Br J Psychiatry; 1995 Mar; 166(3):382-5. PubMed ID: 7788132
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites.
    Gold PW; Goodwin FK; Wehr T; Rebar R
    Am J Psychiatry; 1977 Sep; 134(9):1028-31. PubMed ID: 409301
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cognitive functions and cognitive styles in young euthymic patients with bipolar I disorder.
    Fakhry H; El Ghonemy SH; Salem A
    J Affect Disord; 2013 Oct; 151(1):369-77. PubMed ID: 23830859
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elevated cerebrospinal fluid level of substance P and decreased undecapeptidase activity at term pregnancy.
    Liu Z; Lyrenäs S; Thörnwall M; Le Grevés P; Nyberg F
    Neuropeptides; 1997 Oct; 31(5):415-21. PubMed ID: 9413017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Calcium function in affective disorders and healthy controls.
    Bowden CL; Huang LG; Javors MA; Johnson JM; Seleshi E; McIntyre K; Contreras S; Maas JW
    Biol Psychiatry; 1988 Feb; 23(4):367-76. PubMed ID: 2963665
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Erythrocyte glycine in depressed, hypomanic, and euthymic bipolar patients treated with lithium carbonate.
    Peselow ED; Deutsch SI; Stanley M; Banay-Schwartz M; Virgilio J; Fieve RR
    Psychopharmacology (Berl); 1982; 78(4):314-6. PubMed ID: 6818590
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study.
    González-Pinto A; Alberich S; Barbeito S; Alonso M; Vieta E; Martínez-Arán A; Saenz M; López P
    J Affect Disord; 2010 Aug; 124(3):250-5. PubMed ID: 19959240
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hormonal responses during insulin-induced hypoglycemia in manic-depressed, unipolar depressed, and healthy control subjects.
    Amsterdam JD; Maislin G
    J Clin Endocrinol Metab; 1991 Sep; 73(3):541-8. PubMed ID: 1874932
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats.
    Calcutt NA; Stiller C; Gustafsson H; Malmberg AB
    Brain Res; 2000 Feb; 856(1-2):20-7. PubMed ID: 10677607
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up.
    Goldberg JF; Harrow M
    J Affect Disord; 2004 Aug; 81(2):123-31. PubMed ID: 15306137
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Substance P-like immunoreactivity in human cerebrospinal fluid.
    Higa T; Wood G; Desiderio DM
    Int J Pept Protein Res; 1989 Jun; 33(6):446-51. PubMed ID: 2476411
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Substance P-like immunoreactivity and analgesic effects of vibratory stimulation on patients suffering from chronic pain.
    Guieu R; Tardy-Gervet MF; Giraud P
    Can J Neurol Sci; 1993 May; 20(2):138-41. PubMed ID: 7687513
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A high-recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid.
    Liu Z; Welin M; Bragee B; Nyberg F
    Peptides; 2000 Jun; 21(6):853-60. PubMed ID: 10959008
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Understanding the Biological Relationship between Migraine and Depression.
    Viudez-Martínez A; Torregrosa AB; Navarrete F; García-Gutiérrez MS
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397400
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proteolysis controls endogenous substance P levels.
    Mitchell AJ; Lone AM; Tinoco AD; Saghatelian A
    PLoS One; 2013; 8(7):e68638. PubMed ID: 23894327
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A new mouse model for mania shares genetic correlates with human bipolar disorder.
    Saul MC; Gessay GM; Gammie SC
    PLoS One; 2012; 7(6):e38128. PubMed ID: 22675514
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.
    Douglas SD; Leeman SE
    Ann N Y Acad Sci; 2011 Jan; 1217():83-95. PubMed ID: 21091716
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potential of levetiracetam in mood disorders: a preliminary review.
    Muralidharan A; Bhagwagar Z
    CNS Drugs; 2006; 20(12):969-79. PubMed ID: 17140277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.